Home LiteratureArticle Details
PMID: 26056819 Published · epublish English Journal Article Research Support, Non-U.S. Gov't

Molecular Characterization of NF1 and Neurofibromatosis Type 1 Genotype-Phenotype Correlations in a Chinese Population.

Scientific reports ·Vol. 5 ·2015-06-09 ·页码 11291

Zhang J, Tong H, Fu X, Zhang Y, Liu J, Cheng R, Liang J, Peng J, Sun Z, Liu H, Zhang F, Lu W, Li M, Yao Z

Abstract

Neurofibromatosis type 1 (NF1) is an autosomal dominant hereditary disease that is primarily characterized by multiple café au-lait spots (CALs) and skin neurofibromas, which are attributed to defects in the tumor suppressor NF1. Because of the age-dependent presentation of NF1, it is often difficult to make an early clinical diagnosis. Moreover, identifying genetic alterations in NF1 patients represents a complex challenge. Currently, there are no effective detective methods, and no comprehensive NF1 mutation data are available for mainland China. We screened 109 Chinese patients from 100 families with NF1-like phenotypes (e.g., CALs, neurofibromas, etc.) using Sanger sequencing, multiplex ligation-dependent probe amplification and cDNA sequencing. NF1 mutations were identified in 97 individuals, among which 34 intragenic mutations have not previously been reported. Our exhaustive mutational analysis detected mutations in 89% (89/100) of the NF1-like probands and 93% (70/75) of subjects fulfilling the National Institutes of Health (NIH) criteria. Our findings indicate that individuals who exclusively present with multiple CALs exhibit a high possibility (76%) of having NF1 and show a significantly lower mutation rate (p = 0.042) compared with subjects who fulfill the NIH criteria, providing clinicians with the information that subjects only with multiple CALs harbor a considerable possibility (24%) of being attributed to other comparable diseases.

MeSH 主题词
China Genes, Neurofibromatosis 1 Genotype Humans Neurofibromatosis 1/genetics Phenotype
作者与单位
共 14 位作者,点击展开单位 / ORCID
Zhang Jia
Department of Dermatology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200092, China.
Tong Hanxing
Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Fu Xi'an
Shandong Provincial Institute of Dermatology and Venereology, Shandong, 250022, China.
Zhang Yong
Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Liu Jiangbo
Department of Dermatology, Bao'an Maternal and Child Health Hospital, Shenzhen, Guangdong, 518000, China.
Cheng Ruhong
Department of Dermatology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200092, China.
Liang Jianying
Department of Dermatology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200092, China.
Peng Jie
Department of ophthalmology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200092, China.
Sun Zhonghui
Department of Dermatology, Fengxian Institute of Dermatosis Prevention, Shanghai, 201408, China.
Liu Hong
Shandong Provincial Institute of Dermatology and Venereology, Shandong, 250022, China.
Zhang Furen
Shandong Provincial Institute of Dermatology and Venereology, Shandong, 250022, China.
Lu Weiqi
Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Li Ming
Department of Dermatology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200092, China.
Yao Zhirong
Department of Dermatology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200092, China.
Article Info
Journal
Scientific reports
Abbr.
Sci Rep
ISSN
2045-2322
Published
2015-06-09
电子出版
2015-00-09
页码
11291
Language
English
Country/Region
England
NLM ID
101563288
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com